Form 4: Hims & Hers Health CFO Oluyemi Okupe Reports Acquisition of 183,719 Restricted Stock Units
SEC Form 4 Filing
Chief Financial Officer of Hims & Hers Health, Oluyemi Okupe, reports the acquisition of 183,719 Restricted Stock Units (RSUs) tied to Class A Common Stock, vesting quarterly over four years.
Summary
- Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., filed a Form 4 with the SEC.
- The filing reports the acquisition of 183,719 Restricted Stock Units (RSUs) on March 3, 2025.
- Each RSU represents a contingent right to receive one share of Class A Common Stock.
- The RSUs vest in substantially equal quarterly installments over a 4-year period, starting June 15, 2025.
- The vesting dates are March 15, June 15, September 15, and December 15 of each year.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and suggests confidence in the company's future. There are no immediate negative implications.
Positives
- The acquisition of RSUs by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedule of the RSUs suggests a commitment from the CFO to remain with the company for at least four years.
Industry Context
This type of equity compensation is common in the tech and healthcare industries to align management's interests with those of shareholders and incentivize long-term growth.
Comparison to Industry Standards
- Equity compensation, such as RSUs, is a standard practice among publicly traded companies, particularly in the technology and healthcare sectors, to attract and retain key executives.
- The vesting schedule of four years with quarterly installments is also a common structure, aligning with industry norms for long-term incentive plans.
- Comparing Hims & Hers' equity compensation practices to companies like Teladoc Health or GoodRx, which also operate in the telehealth space, would provide a more detailed benchmark.
Stakeholder Impact
- Shareholders may view the RSU grant as a positive sign, aligning management's interests with the company's long-term success.
- Employees may see this as a sign of stability and commitment from the executive team.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the transaction: acquisition of 183,719 Restricted Stock Units. |
| 03/05/2025 | Date of the signature on the Form 4 filing. |
| 06/15/2025 | First Company Quarterly Vesting Date for the RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.